RELMADA THERAPEUTICS, INC. Other Receivables, Net, Current
RELMADA THERAPEUTICS, INC. (RLMD) had Other Receivables, Net, Current of $512.43 thousand as of 2022-12-31, per its 10-Q filed 2023-11-08.
Discontinued › Notes › Nontrade Receivables
us-gaap:OtherReceivablesNetCurrent · last filed 2023-11-08
- 2022-12-31: Other Receivables, Net, Current $512.43K.
- 2020-03-31: Other Receivables, Net, Current $7.53K.
- 2019-06-30: Other Receivables, Net, Current $176.98K.
- 2018-06-30: Other Receivables, Net, Current $7.62K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2022-12-31 | $512.43K 10-Q · filed 2023-11-08 |
| 2020-03-31 | $7.53K 10-Q · filed 2020-05-15 |
| 2019-06-30 | $176.98K 10-K · filed 2021-03-24 |
| 2018-06-30 | $7.62K 10-KT · filed 2020-03-26 |
| 2017-09-30 | $150.62K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $232.60K 10-K · filed 2018-09-28 |
| 2016-12-31 | $2.35K 10-Q · filed 2017-02-10 |
| 2016-09-30 | $2.35K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $231.94K 10-K · filed 2017-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |